| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
AJP - Endocrinology and Metabolism, Vol 265, Issue 5 E783-E793, Copyright © 1993 by American Physiological Society
ARTICLES |
T. Shiba, T. Inoguchi, J. R. Sportsman, W. F. Heath, S. Bursell and G. L. King
Joslin Diabetes Center, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02215.
The increases in diacylglycerol (DAG) level and protein kinase C (PKC) activity have been characterized biochemically and functionally in the retina and the brain of diabetic rats as well as in cultured vascular cells. PKC specific activities were increased in the membraneous fraction of retina from streptozotocin (STZ)-induced diabetic rats and the genetically determined diabetic BB rats, respectively, after 1 or 2 wk of diabetes, compared with control. The ratio of total PKC activities from membraneous and cytosol fractions was also increased in the retina of diabetic rats. With diabetes, all the isoenzymes and the total DAG level were increased in the rat retina, whereas no changes were found in the rat brain. Insulin treatment normalized plasma glucose levels and partially prevented the increases in the membraneous PKC activity and all the isoenzymes in the retina. In the retinal endothelial cells, the total DAG level and PKC specific activities are increased by 36 and 22%, respectively, in the membraneous pool when the glucose levels are changed from 5.5 to 22 mM. Activation of PKC activity and isoform beta II by the vitreal injection of phorbol dibutyrate mimicked the abnormal retinal blood circulation observed in diabetic rats (2.22 +/- 0.24 vs. 1.83 +/- 0.40 s). Thus diabetes and elevated glucose levels will increase DAG level and PKC activities and its isoenzyme specifically in vascular cells and may affect retinal hemodynamics.
This article has been cited by other articles:
|
|
 |
|
  L. Kong, M. Andrassy, J. S. Chang, C. Huang, T. Asai, M. J. Szabolcs, S. Homma, R. Liu, Y. S. Zou, M. Leitges, et al. PKC{beta} modulates ischemia-reperfusion injury in the heart Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1862 - H1870. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Campbell, W. E. Allen, J. A. Silversides, and E. R. Trimble Glucose-Induced Phosphatidylinositol 3-Kinase and Mitogen-Activated Protein Kinase-Dependent Upregulation of the Platelet-Derived Growth Factor-{beta} Receptor Potentiates Vascular Smooth Muscle Cell Chemotaxis Diabetes, February 1, 2003; 52(2): 519 - 526. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Guo, M. H. Wu, F. Korompai, and S. Y. Yuan Upregulation of PKC genes and isozymes in cardiovascular tissues during early stages of experimental diabetes Physiol Genomics, January 15, 2003; 12(2): 139 - 146. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Kowluru and P. Koppolu Termination of Experimental Galactosemia in Rats, and Progression of Retinal Metabolic Abnormalities Invest. Ophthalmol. Vis. Sci., October 1, 2002; 43(10): 3287 - 3291. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. Ring, J. S. Gillespie, S. N. Binkley, K. M. Campanale, and S. A. Wrighton The Interactions of a Selective Protein Kinase C Beta Inhibitor with the Human Cytochromes P450 Drug Metab. Dispos., September 1, 2002; 30(9): 957 - 961. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Hiramatsu, N. Sekiguchi, M. Hayashi, K. Isshiki, T. Yokota, G. L. King, and M. R. Loeken Diacylglycerol Production and Protein Kinase C Activity Are Increased in a Mouse Model of Diabetic Embryopathy Diabetes, September 1, 2002; 51(9): 2804 - 2810. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C.P. Thirone, J. A. Scarlett, A. L. Gasparetti, E. P. Araujo, M. H.L. Lima, C. R.O. Carvalho, L. A. Velloso, and M. J.A. Saad Modulation of Growth Hormone Signal Transduction in Kidneys of Streptozotocin-Induced Diabetic Animals: Effect of a Growth Hormone Receptor Antagonist Diabetes, July 1, 2002; 51(7): 2270 - 2281. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. G. Bohlen and G. P. Nase Obesity lowers hyperglycemic threshold for impaired in vivo endothelial nitric oxide function Am J Physiol Heart Circ Physiol, July 1, 2002; 283(1): H391 - H397. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Booth, T. J. Stalker, A. M. Lefer, and R. Scalia Mechanisms of Amelioration of Glucose-Induced Endothelial Dysfunction Following Inhibition of Protein Kinase C In Vivo Diabetes, May 1, 2002; 51(5): 1556 - 1564. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Malhotra, B. P.S. Kang, S. Cheung, D. Opawumi, and L. G. Meggs Angiotensin II Promotes Glucose-Induced Activation of Cardiac Protein Kinase C Isozymes and Phosphorylation of Troponin I Diabetes, August 1, 2001; 50(8): 1918 - 1926. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. G. Bohlen and G. P. Nase Arteriolar nitric oxide concentration is decreased during hyperglycemia-induced {beta}II PKC activation Am J Physiol Heart Circ Physiol, February 1, 2001; 280(2): H621 - H627. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Mori, G. L. King, A. C. Clermont, D. K. Bursell, and S.-E. Bursell Endothelin-3 Regulation of Retinal Hemodynamics in Nondiabetic and Diabetic Rats Invest. Ophthalmol. Vis. Sci., November 1, 2000; 41(12): 3955 - 3962. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Y. Yuan, E. E. Ustinova, M. H. Wu, J. H. Tinsley, W. Xu, F. L. Korompai, and A. C. Taulman Protein Kinase C Activation Contributes to Microvascular Barrier Dysfunction in the Heart at Early Stages of Diabetes Circ. Res., September 1, 2000; 87(5): 412 - 417. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Nonaka, J. Kiryu, A. Tsujikawa, K. Yamashiro, K. Miyamoto, H. Nishiwaki, Y. Honda, and Y. Ogura PKC-{beta} Inhibitor (LY333531) Attenuates Leukocyte Entrapment in Retinal Microcirculation of Diabetic Rats Invest. Ophthalmol. Vis. Sci., August 1, 2000; 41(9): 2702 - 2706. [Abstract] [Full Text]
|
|
|
|
|
|
H. Sone, B. K. Deo, and A. K. Kumagai Enhancement of Glucose Transport by Vascular Endothelial Growth Factor in Retinal Endothelial Cells Invest. Ophthalmol. Vis. Sci., June 1, 2000; 41(7): 1876 - 1884. [Abstract] [Full Text]
|
|
|
|
 |
|
 E. Villard, A. Alonso, M. Agrapart, M. Challah, and F. Soubrier Induction of Angiotensin I-converting Enzyme Transcription by a Protein Kinase C-dependent Mechanism in Human Endothelial Cells J. Biol. Chem., September 25, 1998; 273(39): 25191 - 25197. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. B. Williams, A. B. Goldfine, F. K. Timimi, H. H. Ting, M.-A. Roddy, D. C. Simonson, and M. A. Creager Acute Hyperglycemia Attenuates Endothelium-Dependent Vasodilation in Humans In Vivo Circulation, May 5, 1998; 97(17): 1695 - 1701. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. D. Giles, J. Ouyang, E. K. Kerut, M. B. Given, G. E. Allen, E. F. McIlwain, and S. S. Greenberg Changes in protein kinase C in early cardiomyopathy and in gracilis muscle in the BB/Wor diabetic rat Am J Physiol Heart Circ Physiol, January 1, 1998; 274(1): H295 - H307. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Hempel, C. Maasch, U. Heintze, C. Lindschau, R. Dietz, F. C. Luft, and H. Haller High Glucose Concentrations Increase Endothelial Cell Permeability via Activation of Protein Kinase C{alpha} Circ. Res., September 19, 1997; 81(3): 363 - 371. [Abstract] [Full Text]
|
|
|
|
 |
|
 H. Wakasaki, D. Koya, F. J. Schoen, M. R. Jirousek, D. K. Ways, B. D. Hoit, R. A. Walsh, and G. L. King Targeted overexpression of protein kinase C beta 2 isoform in myocardium causes cardiomyopathy PNAS, August 19, 1997; 94(17): 9320 - 9325. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
